Apnimed’s star sleep apnea asset has hit the latest landmark on its march down victory road. | Apnimed’s star sleep apnea ...

The clinical syndrome of obstructive sleep apnea (OSAS) in children is a distinct, yet somewhat overlapping disorder with the condition that occurs in adults, such that the clinical manifestations ...

Background: The pathogenesis of daytime hypercapnia (PaCO 2 ≥ 45 mm Hg) may be directly linked to the existence of obstructive sleep apnea syndrome ... and apnea-hypopnea index (AHI) values ...

Standard treatment for breathing problems caused by obstructive ... change in the apnea-hypopnea index, a scale used to measure the breathing reductions or interruptions during sleep (the higher ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Obstructive sleep apnea-hypopnea is widely considered to be a cardiovascular risk factor, but there are few prospective data to confirm this link or to establish whether treating the condition ...

Is There a Cure for Sleep Apnea? There isn't a cure for it, especially for obstructive sleep apnea ... but it is not the same as the Apnea-Hypopnea Index (AHI) score that doctors use to check ...

Obstructive sleep apnea (OSA), commonly associated with cardiovascular and metabolic diseases, also plays a significant but ...

WASHINGTON, D.C. — The fight against obstructive ... fewer instances of apnea (temporary cessation of breathing) and hypopnea (shallow breathing) occurred during sleep. What’s more, many ...

The FDA approved tirzepatide (Zepbound) for adults with moderate-to-severe obstructive sleep apnea (OSA ... mean change at ...